NPPB and COVID-19: To observe the increment in discrimination among the models including different biomarkers, we assessed the predictive role for the main composite outcome in a model including classical cardiovascular risk factors (model 1), to which we added NT-pro BNP in patients with COVID-19 (model 2) and hs-TnI (model 3).